← Back
$LENZ All transactions

LENZ Therapeutics, Inc.

▲ BUY
10 / 10

Conviction

$ Value

$251K

Shares

28,089

Price

$9

Filed

Mar 30

Why this score? (10/10)
  • Open market buy (+3)
  • Trade value >= $250K (+1)
  • % of holdings >= 20% (+2)
  • C-suite insider (+2)
  • Director (+1)
  • Cluster: 3 insiders buying (+2)
  • Not a 10b5-1 plan (+1)

Insider

Name

Schimmelpennink Evert B.

Title

President, CEO and Secretary

CIK

0001713795

Roles

Director Officer

Transaction Details

Transaction Date

2026-03-27

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

77,289

Footnotes

Represents the weighted average share price of an aggregate total of 28,089 shares purchased in the price range of $8.80 to $9.25 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Filing Info

Accession No.

0001713795-26-000004

Form Type

4

Issuer CIK

0001815776

Schimmelpennink Evert B.'s History

Date Ticker Type Value
2026-03-27 LENZ $251K
2026-01-02 LENZ A $0
2025-11-20 IBIO A $0
2025-06-26 CTNM A $0

Other Insiders at LENZ (90d)

Insider Bought Sold Last
Chevallard Daniel R.
Chief Financial Officer
$64K 2026-03-27
George Jeffrey P. $50K 2026-03-27